Alpha 2.0
Login Register
» Authors » Philippe Page

Philippe Page

Explore the profile of Philippe Page including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 27
Citations 448
Followers 0
Related Specialties
General Medicine
Neurology
Neurosurgery
Top 10 Co-Authors
Maxime Billot
Manuel Roulaud
Philippe Rigoard
Amine Ounajim
Kevin Nivole
Lisa Goudman
Romain David
Maarten Moens
Bertille Lorgeoux
Sandrine Baron
Published In
J Clin Med
Neurosurgery
Neuro Oncol
iScience
Br J Haematol
Affiliations
Soon will be listed here.
Recent Articles
1.
A digital tool for multidimensional assessment and prediction of treatment effectiveness in chronic pain management
Rigoard P, Ounajim A, Moens M, Goudman L, Roulaud M, Naiditch N, et al.
iScience . 2025 Jan; 27(12):111200. PMID: 39758999
Given the multidimensional aspect of pain, the assessment of treatment efficacy is challenging. The prospective observational multicenter PREDIBACK study aimed to assess, compare, and predict the effectiveness of different treatments...
2.
Histology independent drug development - Is this the future for cancer drugs?
Billingham L, Brown L, Framke T, Greystoke A, Hovig E, Mathur S, et al.
Cancer Treat Rev . 2024 Jan; 123:102674. PMID: 38176220
The Cancer Drug Development Forum (CDDF)'s 'Histology independent drug development - is this the future for cancer drugs?' workshop was set up to explore the current landscape of histology independent...
3.
Evaluation of External Trigeminal Nerve Stimulation to Prevent Cerebral Vasospasm after Subarachnoid Hemorrhage Due to Aneurysmal Rupture: A Randomized, Double-Blind Proof-of-Concept Pilot Trial (TRIVASOSTIM Study)
Rigoard P, Billot M, Moens M, Goudman L, El-Hajj H, Ingrand P, et al.
Int J Environ Res Public Health . 2023 May; 20(10). PMID: 37239562
Cerebral vasospasm remains the most frequent and devastating complication after subarachnoid aneurysmal hemorrhage because of secondary cerebral ischemia and its sequelae. The underlying pathophysiology involves vasodilator peptide release (such as...
4.
Combining Awake Anesthesia with Minimal Invasive Surgery Optimizes Intraoperative Surgical Spinal Cord Stimulation Lead Placement
Rigoard P, Ounajim A, Goudman L, Wood C, Roulaud M, Page P, et al.
J Clin Med . 2022 Oct; 11(19). PMID: 36233439
Spinal cord stimulation (SCS) is an effective and validated treatment to address chronic refractory neuropathic pain in persistent spinal pain syndrome-type 2 (PSPS-T2) patients. Surgical SCS lead placement is traditionally...
5.
Comparison of Spinal Cord Stimulation vs. Dorsal Root Ganglion Stimulation vs. Association of Both in Patients with Refractory Chronic Back and/or Lower Limb Neuropathic Pain: An International, Prospective, Randomized, Double-Blinded, Crossover...
Rigoard P, Roulaud M, Goudman L, Adjali N, Ounajim A, Voirin J, et al.
Medicina (Kaunas) . 2022 Jan; 58(1). PMID: 35056316
While spinal cord stimulation (SCS) is a well-established therapy to address refractory persistent spinal pain syndrome after spinal surgery (PSPS-T2), its lack of spatial selectivity and reported discomfort due to...
6.
The Challenge of Converting "Failed Spinal Cord Stimulation Syndrome" Back to Clinical Success, Using SCS Reprogramming as Salvage Therapy, through Neurostimulation Adapters Combined with 3D-Computerized Pain Mapping Assessment: A Real Life...
Rigoard P, Ounajim A, Goudman L, Banor T, Heroux F, Roulaud M, et al.
J Clin Med . 2022 Jan; 11(1). PMID: 35012013
While paresthesia-based Spinal Cord Stimulation (SCS) has been proven effective as treatment for chronic neuropathic pain, its initial benefits may lead to the development of "Failed SCS Syndrome' (FSCSS) defined...
7.
The Added Value of Subcutaneous Peripheral Nerve Field Stimulation Combined with SCS, as Salvage Therapy, for Refractory Low Back Pain Component in Persistent Spinal Pain Syndrome Implanted Patients: A Randomized Controlled Study (CUMPNS Study)...
Rigoard P, Ounajim A, Goudman L, Bouche B, Roulaud M, Page P, et al.
J Clin Med . 2021 Nov; 10(21). PMID: 34768614
While Spinal Cord Stimulation (SCS) provides satisfaction to almost 2/3 of Persistent Spinal Pain Syndrome-Type 2 (PSPS-T2) patients implanted for refractory chronic back and/or leg pain, when not adequately addressed...
8.
Professional Status of Persistent Spinal Pain Syndrome Patients after Spinal Surgery (PSPS-T2): What Really Matters? A Prospective Study Introducing the Concept of "Adapted Professional Activity" Inferred from Clinical, Psychological and Social...
Naiditch N, Billot M, Goudman L, Cornet P, Roulaud M, Ounajim A, et al.
J Clin Med . 2021 Nov; 10(21). PMID: 34768575
Persistent Spinal Pain Syndrome Type 2 (PSPS-T2) represents a main cause of work disruption. Beyond its societal consequences, occupational inactivity is responsible for a major decrease in physical/mental health in...
9.
A Novel Multi-Dimensional Clinical Response Index Dedicated to Improving Global Assessment of Pain in Patients with Persistent Spinal Pain Syndrome after Spinal Surgery, Based on a Real-Life Prospective Multicentric Study (PREDIBACK) and Machine...
Rigoard P, Ounajim A, Goudman L, Louis P, Slaoui Y, Roulaud M, et al.
J Clin Med . 2021 Nov; 10(21). PMID: 34768428
The multidimensionality of chronic pain forces us to look beyond isolated assessment such as pain intensity, which does not consider multiple key parameters, particularly in post-operative Persistent Spinal Pain Syndrome...
10.
Machine Learning Algorithms Provide Greater Prediction of Response to SCS Than Lead Screening Trial: A Predictive AI-Based Multicenter Study
Ounajim A, Billot M, Goudman L, Louis P, Slaoui Y, Roulaud M, et al.
J Clin Med . 2021 Oct; 10(20). PMID: 34682887
Persistent pain after spinal surgery can be successfully addressed by spinal cord stimulation (SCS). International guidelines strongly recommend that a lead trial be performed before any permanent implantation. Recent clinical...